Cyclohexane, 1-bromo-3-(1-bromo-1-methylethyl)-1-methyl-(1129-18-6)
- Name: Cyclohexane, 1-bromo-3-(1-bromo-1-methylethyl)-1-methyl-
- Synonyms:
- Molecular Formula:C10H18Br2
- Molecular Weight:298.061
- CAS Registry Number:1129-18-6
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1129-18-6 Cyclohexane, 1-bromo-3-(1-bromo-1-methylethyl)-1-methyl-
Assay:95% Application:Synthetic building block
Min. Order:0
Supplier:SAGECHEM LIMITED [
China (Mainland)]
Other Product
- 112917-98-3/Acetic acid, [4-[3-[(phenylsulfonyl)amino]bicyclo[2.2.1]hept-2-yl]phenoxy]-, methyl ester, (2-exo,3-endo)-
- 112917-99-4/Acetic acid, [4-[3-[(phenylsulfonyl)amino]bicyclo[2.2.1]hept-2-yl]phenoxy]-, (2-exo,3-endo)-
- 112918-10-2/Carbamic acid, (3-formyl-7-oxabicyclo[2.2.1]hept-2-yl)-, phenylmethyl ester
- 112918-13-5/Carbamic acid, [3-(2-methoxyethenyl)-7-oxabicyclo[2.2.1]hept-2-yl]-, phenylmethyl ester
- 112918-14-6/Carbamic acid, [3-(2-oxoethyl)-7-oxabicyclo[2.2.1]hept-2-yl]-, phenylmethyl ester
- 112918-15-7/5-Heptenoic acid, 7-[3-[[(phenylmethoxy)carbonyl]amino]-7-oxabicyclo[2.2.1]hept-2-yl]-, methyl ester
- 112918-16-8/5-Heptenoic acid, 7-[3-[[(1,1-dimethylethoxy)carbonyl]amino]-7-oxabicyclo[2.2.1]hept-2-yl]- , methyl ester
- 112918-17-9/Carbamic acid, [3-(cyanomethyl)-7-oxabicyclo[2.2.1]hept-2-yl]-, 1,1-dimethylethyl ester, (2-endo,3-exo)-
- 112918-18-0/Carbamic acid, [3-(2-oxoethyl)-7-oxabicyclo[2.2.1]hept-2-yl]-, 1,1-dimethylethyl ester, (2-endo,3-exo)-
- 112918-19-1/Bicyclo[2.2.2]octanone, 3-(2-propenyl)-, oxime
- 112918-20-4/Bicyclo[2.2.2]octan-2-amine, 3-(2-propenyl)-
- 112918-21-5/Benzenesulfonamide, N-[3-(2-propenyl)bicyclo[2.2.2]oct-2-yl]-
- 112918-22-6/Benzenesulfonamide, N-[3-(oxiranylmethyl)bicyclo[2.2.2]oct-2-yl]-
- 112918-23-7/Benzenesulfonamide, N-[3-(2-oxoethyl)bicyclo[2.2.2]oct-2-yl]-, trans-
- 112918-40-8/Carbamic acid, [2-[[[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy] acetyl]amino]ethyl]-, phenylmethyl ester
- 112918-42-0/Acetamide, N-(2-aminoethyl)-2-[4-[2,3,6,7-tetrahydro-2,6-dioxo-7-(phenylmethyl)-1, 3-dipropyl-1H-purin-8-yl]phenoxy]-
- 112918-44-2/Carbamic acid, [1-[(4-nitrophenyl)methyl]-2-oxo-2-[[2-[[[4-(2,3,6,7-tetrahydro-2,6-dioxo-1 ,3-dipropyl-1H-purin-8-yl)phenoxy]acetyl]amino]ethyl]amino]ethyl]-, 1,1-dimethylethyl ester, (R)-
- 112918-45-3/Carbamic acid, [1-[(4-aminophenyl)methyl]-2-oxo-2-[[2-[[[4-(2,3,6,7-tetrahydro-2,6-dioxo -1,3-dipropyl-1H-purin-8-yl)phenoxy]acetyl]amino]ethyl]amino]ethyl]-, 1,1-dimethylethyl ester, (R)-
- 112918-58-8/Glycinamide, L-tyrosyl-N-[2-[[[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8- yl)phenoxy]acetyl]amino]ethyl]-, monohydrobromide
- 1129-18-6/Cyclohexane, 1-bromo-3-(1-bromo-1-methylethyl)-1-methyl-
- 112918-61-3/L-Valinamide, L-tyrosyl-N-[2-[[[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8- yl)phenoxy]acetyl]amino]ethyl]-, monohydrobromide
- 112918-63-5/Tetradecanoic acid, 2-[[[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy] acetyl]oxy]-1,3-propanediyl ester
- 112918-67-9/Adenosine, N-[4-[2-oxo-2-[[4-[2-oxo-2-[[2-[(1-oxooctadecyl)amino]ethyl]amino]ethyl] phenyl]amino]ethyl]phenyl]-
- 112918-70-4/Acetamide, N-[2-(acetyloxy)ethyl]-2-[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H -purin-8-yl)phenoxy]-
- 112918-71-5/Octadecanoic acid, 2-[[[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy] acetyl]amino]ethyl ester
- 112918-72-6/9-Octadecenoic acid, 2-[[[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy] acetyl]amino]ethyl ester, (E)-
- 112918-74-8/Glycine, N-[2-oxo-2-[[2-[[[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8 -yl)phenoxy]acetyl]amino]ethyl]amino]ethyl]-
- 112918-75-9/Acetamide, N-phenyl-2-[4-(2,3,6,7-tetrahydro-1,3-dimethyl-2,6-dioxo-1H-purin-8-yl) phenoxy]-
- 112918-76-0/L-Glutamic acid, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, 5-(4-nitrophenyl) 1-(phenylmethyl) ester
- 112918-78-2/Carbamic acid, [4-[2-[(2-aminoethyl)amino]-2-oxoethyl]phenyl]-, 1,1-dimethylethyl ester